Tyruko, the first natalizumab biosimilar for multiple sclerosis, promises significant savings and competition in the US market.

"We are grateful to U.S. Senators Roger Wicker (R-MS) and Shelley Moore Capito (R-WV) for their leadership on this vital issue. They recognize that the promise of AI must extend beyond major cities ...

Satya Nadella's path from aspiring cricketer and would-be banker in India to Microsoft CEO was shaped by missing out on IIT, ...

The latest example of the technology’s proliferation being forced down users’ throats, likely in the name of artificially ...

The mobile app for Microsoft Lists has been discontinued. While this is a loss for corporate users who use their smartphones ...

Microsoft announced Tuesday that it will spend more than $7.5 billion over the next two years to build new AI and digital infrastructure to shore up Canada’s digital sovereignty. The U.S.-based tech ...

The White House is taking aim at MS NOW correspondent Ken Dilanian over his initial reaction to Wednesday's shooting of National Guard troops in Washington D.C. Dilanian appeared during the network's ...